445 related articles for article (PubMed ID: 25690160)
1. Intravesical injection of botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome: 10 years of experience at a single center in China.
Gao Y; Liao L
Int Urogynecol J; 2015 Jul; 26(7):1021-6. PubMed ID: 25690160
[TBL] [Abstract][Full Text] [Related]
2. An indirect comparison meta-analysis of noninvasive intravesical instillation and intravesical injection of botulinum toxin-A in bladder disorders.
Yunfeng G; Fei L; Junbo L; Dingyuan Y; Chaoyou H
Int Urol Nephrol; 2022 Mar; 54(3):479-491. PubMed ID: 35044552
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intravesical instillation of hyaluronic acid with intradetrusor botulinum toxin A injection or cystoscopic hydrodistention for ketamine-associated cystitis.
Li B; Leng Q; Li C; Tan X; Su W; Li C
J Int Med Res; 2020 Nov; 48(11):300060520973100. PubMed ID: 33259240
[TBL] [Abstract][Full Text] [Related]
4. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
5. Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study.
Rappaport YH; Zisman A; Jeshurun-Gutshtat M; Gerassi T; Hakim G; Vinshtok Y; Stav K
Urology; 2018 Apr; 114():60-65. PubMed ID: 29307733
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
Lee CL; Kuo HC
Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388
[TBL] [Abstract][Full Text] [Related]
7. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
[TBL] [Abstract][Full Text] [Related]
8. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
Kuo HC; Jiang YH; Tsai YC; Kuo YC
Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
[TBL] [Abstract][Full Text] [Related]
9. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
Dellis A; Papatsoris AG
Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
[TBL] [Abstract][Full Text] [Related]
10. Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis.
Peng CH; Jhang JF; Shie JH; Kuo HC
Urology; 2013 Dec; 82(6):1452.e1-6. PubMed ID: 24295265
[TBL] [Abstract][Full Text] [Related]
11. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
Kuo HC
Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome.
Shie JH; Liu HT; Wang YS; Kuo HC
BJU Int; 2013 Apr; 111(4):638-46. PubMed ID: 22943596
[TBL] [Abstract][Full Text] [Related]
13. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
Chuang YC; Kuo HC
J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
[TBL] [Abstract][Full Text] [Related]
14. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
Chung SD; Kuo YC; Kuo HC
Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
[TBL] [Abstract][Full Text] [Related]
15. Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome.
Kuo HC
Pain Physician; 2013 Jan; 16(1):E15-23. PubMed ID: 23340540
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
Jhang JF; Yu WR; Kuo HC
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
[TBL] [Abstract][Full Text] [Related]
17. Injection location does not impact botulinum toxin A efficacy in interstitial cystitis/bladder pain syndrome patients.
Evans RJ; Overholt T; Colaco M; Walker SJ
Can J Urol; 2020 Feb; 27(1):10125-10129. PubMed ID: 32065870
[TBL] [Abstract][Full Text] [Related]
18. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
[TBL] [Abstract][Full Text] [Related]
19. Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: Do onabotulinum toxin-A injections improve sexual function?
Topcuoglu M; Karaburun MC; İbiş A; Gokce Mİ; Süer E; Gülpinar O
Neurourol Urodyn; 2023 Mar; 42(3):607-614. PubMed ID: 36708358
[TBL] [Abstract][Full Text] [Related]
20. Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Wang HJ; Yu WR; Ong HL; Kuo HC
Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31752328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
